✦ LIBER ✦

Improved survival and quality of life in patients undergoing R1 pancreatic resection compared to patients with locally advanced unresectable pancreatic adenocarcinoma

✍ Scribed by Nordby, Tom; Ikdahl, Tone; Bowitz Lothe, Inger Marie; Fagerland, Morten W.; Heiberg, Turid; Hauge, Truls; Labori, Knut Joergen; Buanes, Trond

Book ID: 122579143
Publisher: S. Karger AG
Year: 2013
Tongue: English
Weight: 287 KB
Volume: 13
Category: Article
ISSN: 1424-3903
DOI: 10.1016/j.pan.2013.01.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Palliative partial pancreaticoduodenecto

Palliative partial pancreaticoduodenectomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of the pancreatic head

✍ J. Walter; A. Nier; T. Rose; J.H. Egberts; C. Schafmayer; T. Kuechler; D.C. Broe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Survival Outcome of a Phase 1 Trial: Hyp

Survival Outcome of a Phase 1 Trial: Hypofractionated Stereotactic Body Radiation Therapy Concurrent With Nelfinavir Following Gemcitabine and 5FU in Patients With Locally Advanced Pancreatic Adenocarcinoma

✍ Lin, C.; Sasson, A.R.; Ly, Q.P.; Schwarz, J.K.; Are, C.; Kos, B.M.; Lazenby, A.J 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Endoscopic Ultrasound-Guided Celiac Plex

Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis (EUS-CPN) in Patients with Locally Advanced and Unresectable Pancreatic Adenocarcinoma: A Randomized Prospective Study of 10 mL Versus 20 mL of Alcohol

✍ Julia K. Leblanc; Michelle Symms; Susan M. Rawl; Cynthia S. Johnson; John M. DeW 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Adding irinotecan to first-line gemcitab

Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer: Abstracted from: Rocha Lima CM, Green MR, Rotche R et al. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumour response rate. J Clin Oncol 2004;22:3776–83.

✍ Desmond Yip; David Goldstein 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 103 KB